Ignite Creation Date:
2024-05-06 @ 3:49 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02380339
Status:
UNKNOWN
Last Update Posted:
2019-09-11
First Post:
2015-03-02
Brief Title:
A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia
Sponsor:
Hadassah Medical Organization
Organization:
Hadassah Medical Organization
Study Overview
Official Title:
A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia
Status:
UNKNOWN
Status Verified Date:
2019-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Uncontrolled diabetes is associated with increased risk for micro-vascular complication Hypoglycemia is one of the major barriers in achieving good glucose control Hypoglycemia is associated with a range of unpleasant symptoms including palpitations tremor hunger sweating confusion difficulties in thinking as well as other idiosyncratic symptoms Fear of hypoglycemia FOH refers to phobic avoidance reactions associated with hypoglycemia FOH may increase behavioral attempts to avoid hypoglycemia including decreased consumption of insulin andor increased consumption of carbohydrates resulting in poor glycemic control and an increased risk of diabetic complication In this study the investigators present a novel system which simultaneously employs BioFeedback and Virtual Reality in order to cope with fear of hypoglycemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None